Rising Global Footprint, Best-in-Class Innovation, and ESG Excellence Set Stage for Sustained Value CreationPISCATAWAY, N.J., Aug. 17, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 2025, underscoring its ability to deliver profitable growth at scale through strategic globalization, differentiated technology, and relentless innovation.Fueled by robust demand across all business segm ...